Students in the Master’s programme in Bio-Pharmaceutical Sciences (BPS) of Leiden University are trained for a scientific career in drug research and development. Depending on their interests, students can choose from seven specialisations to further extend their scientific training and theoretical background or supplement it with other subjects and training.
The duration of each programme variant is two years (120 EC). Students who complete the programme receive the degree Master of Science in Bio-Pharmaceutical Sciences, with specification of the specialisation. All students who complete the master Bio-Pharmaceutical Sciences, regardless of the specialisation, are admissible to a PhD programme in Bio-Pharmaceutical, Biomedical or other Life Sciences.
The Master’s Programme offers three major Research Specialisations corresponding to the disciplines of the Research Divisions of the Leiden Academic Centre for Drug Research (LACDR): Drug & Target Discovery (division of Drug Discovery & Safety) BioTherapeutics (division of BioTherapeutics) and Systems Pharmacology (division of Systems Biomedicine and Pharmacology).
The remaining four BPS tracks consist of a research component in combination with another specialisation in either Science-Based Business (SBB), Science Communication and Society (SCS), Education (EDU) or the new pilot track Industrial Pharmacy (IP; max. 2 selected participants).